|
|
||||||||
a Division of Cardiothoracic Surgery, Pinehurst Surgical Clinics, Pinehurst, North Carolina
b Klinikum der Johann Wolfgang Goethe-Universitat, Frankfurt, Germany
c Brody School of Medicine at East Carolina University, Greenville, North Carolina
Accepted for publication August 14, 2007.
* Address correspondence to Dr Kiser, Pinehurst Surgical Clinics, Cardiac and Thoracic Surgery, 5 FirstVillage Dr, Pinehurst, NC 28374 (Email: akiser{at}pinehurstsurgical.com).
| Drs Kiser and Wimmer-Greinecker disclose that they have a financial relationship with nContact Surgical Inc.
|
| Abstract |
|---|
|
|
|---|
Despite innovations, a complete Cox Maze III procedure cannot be performed on the beating heart. Less complex Maze-like procedures generally limit treatment to the left atrium alone. However, the best surgical treatment for atrial fibrillation is the complete, biatrial Maze III lesion pattern [1, 2]. A novel radiofrequency ablation device (nContact Surgical Inc, Morrisville, NC) can create transmural ablative lesions in any pattern on a beating heart. We describe an ablation pattern, performed totally on the epicardium, which closely imitates the gold standard Maze III procedure (Fig 1).
|
| Technique |
|---|
|
|
|---|
Device Description
The ablation device uses unipolar radiofrequency energy with vacuum-maintained contact and suction-controlled saline perfusion to ensure uniform energy transmission and transmural lesion development. The average energy delivered is 50 W for 90 seconds. Suction encourages the electrode coil into approximation with the epicardial surface, thus ensuring consistent contact. The flexible low-profile device conforms to the anatomic surface of the heart. The device can be manipulated manually or guided with a tether. The ablation lesions are clearly visible on the myocardium, allowing the surgeon to create continuous lesion patterns on the epicardium (Fig 2).
|
Lesion 1 (Fig 3) is created by positioning the device toward, but not onto, the coronary sinus. Epicardial contact is verified by the audible "seal" of suction with the epicardium and by verifying saline perfusion through the device. The device is withdrawn behind the left pulmonary veins to create lesion 2. Lesion continuity is visually verified to avoid gaps of viable tissue between individual lesion segments.
|
The device is then repositioned behind the SVC, from medial to lateral, behind the right pulmonary veins, and then behind and medial to the IVC. Lesion 6, the coronary sinus lesion, originates at the location of the Thebesian valve on the medial and inferior surface of the right atrium and extends behind the IVC towards the right inferior pulmonary vein. The device is withdrawn behind the right pulmonary veins to create lesion 7. The device is repositioned along the interatrial groove to create lesion 8 and complete the right pulmonary vein isolation. The device extends from the right pulmonary veins across the right atrium to create lesion 9. Lesion 10 extends from SVC to IVC along the lateral right atrium. The left atrial appendage is excluded or ligated (lesion 11).
The Ex-Maze procedure was performed during 44 concomitant cardiac procedures for patients with atrial fibrillation; of these, 82% of the patients had persistent or permanent atrial fibrillation. The average left atrial size was 5.2 cm. The additional mean ± SEM operative time was 34 ± 4.7 minutes (range, 48 to 20 minutes). Thirty-eight of the 44 patients (86%) presented in the operating room in atrial fibrillation, and 27 (71%) converted to sinus rhythm during the lesion creation.
There were no complications related to the Ex-Maze procedure. Five patients received amiodarone for 4 weeks; the remaining patients did not receive class I or III antiarrhythmic drugs. At 1 month, 66% (21 of 32) patients were in sinus rhythm. At 3 months, 79% (26 of 33) patients were in sinus rhythm.
| Comment |
|---|
|
|
|---|
The Ex-Maze procedure avoids incomplete treatment patterns and pursues a treatment option for all patients with paroxysmal, persistent, or permanent atrial fibrillation.
Because the Ex-Maze does not include cryoablation of the mitral or tricuspid valve annulus, it is not an exact Maze procedure as Cox and colleagues described [3]. Persistent conduction pathways and recurrent atrial arrhythmias (ie, atrial flutter) are theoretically possible [4]. In addition, the right atrial appendage is not excised and the interatrial septum remains intact. However, the Ex-Maze treats both the left and the right atria and is performed without a cross clamp or atriotomy. Diligent creation of the biatrial Ex-Maze lesion pattern resulted in spontaneous conversion to sinus rhythm during lesion creation, signifying interruption of clinically significant macro-reentrant circuits. Of the patients who converted to sinus rhythm during the procedure, 94% did so during one of the lesions that connected the left atrium to the right atrium (eg, lesion 6 or 9 in Fig 1).
The Ex-Maze procedure is an uncomplicated and potentially effective solution for patients with paroxysmal, persistent, or permanent atrial fibrillation who undergo concomitant cardiac procedures. Long-term follow-up at 1, 3, 6, and 12 months to evaluate the clinical success of this procedure is underway.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
F. H. Cheema, J. S. Weisberg, I. Khalid, and H. G. Roberts Jr Warm beating heart, robotic endoscopic cox-cryomaze: an approach for treating atrial fibrillation. Ann. Thorac. Surg., March 1, 2009; 87(3): 966 - 968. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |